Liberty Biopharma Inc (CVE:LTY – Get Free Report) crossed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of C$2.00 and traded as high as C$2.00. Liberty Biopharma shares last traded at C$2.00, with a volume of 700 shares.
Liberty Biopharma Trading Up ∞
The business’s 50 day simple moving average is C$2.00 and its two-hundred day simple moving average is C$2.00. The stock has a market cap of C$21.54 million and a P/E ratio of -12.66. The company has a quick ratio of 0.12, a current ratio of 0.12 and a debt-to-equity ratio of 8.19.
Liberty Biopharma Company Profile
Liberty Biopharma Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.
Featured Articles
- Five stocks we like better than Liberty Biopharma
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- United Airlines Soars on Earnings Beat
- How to Invest in the Best Canadian Stocks
- J.B. Hunt Hits the Skids: Lower Prices to Come
- What Do S&P 500 Stocks Tell Investors About the Market?
- Predicting a Bear Market: 7 Signs and Why it’s Tough to Do
Receive News & Ratings for Liberty Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liberty Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.
